Related Experiment Video
Updated: Jan 23, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
HSDL2 Promotes Bladder Cancer Growth In Vitro and In Vivo
Ling-Hua Jia1,2, Mei-Di Hu3, Yuan Liu4
1Graduate Faculty, Jiangxi Medical College, Nanchang University, Nanchang 330006.
Abstract:
Bladder cancer is a common malignant urinary tumor, and patients with bladder cancer have poor prognosis. Abnormal lipid metabolism in peroxisomes is involved in tumor progression. Hydroxysteroid dehydrogenase-like 2 (HSDL2) localized in peroxisomes regulates fatty acid synthesis. In the present study, we reported that HSDL2 was upregulated in two human bladder cancer cell lines 5637 and T24 compared to normal human urothelial cells. Furthermore, lentiviral-mediated HSDL2 knockdown inhibited the proliferation and colony formation while promoted the apoptosis of human bladder cancer T24 cells in vitro. In nude mice HSDL2 knockdown inhibited the growth of T24 derived xenografts in vivo. In conclusion, our results suggest that HSDL2 plays an oncogenic role in bladder cancer and might serve as a potential target for bladder cancer therapy.
Related Concept Videos
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Equivalence: In Vitro and In Vivo Bioequivalence
Population Growth
Anaphase Promoting Complex

